MARIA KABUSHINSKAYA: Open Payments
NPI 1952811283 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,754 in 109 payments from 18 companies in 2025. Trend: 2023 $4,296 · 2024 $3,431 · 2025 $8,754
Speaker / faculty: $4,200Food & beverage: $3,959Consulting: $500Education: $67Travel & lodging: $29
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 11 | $4,478 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $608 |
| Arcutis Biotherapeutics, Inc. | 12 | $601 |
| Botanix SB Inc | 5 | $578 |
| ABBVIE INC. | 20 | $564 |
| Janssen Biotech, Inc. | 10 | $554 |
| UCB, Inc. | 6 | $254 |
| PFIZER INC. | 8 | $209 |
| Regeneron Healthcare Solutions, Inc. | 3 | $168 |
| LEO Pharma Inc. | 4 | $161 |
Products named: NEMLUVIO, Zoryve, SOFDRA, TREMFYA, SKYRIZI, ILUMYA, DUPIXENT, Bimzelx.
Industry payments across FL — which companies pay providers there.
